Cipla And mAbxience Partner For Essential Biosimilars In South Africa

Partners Will Focus On Oncology And Respiratory-Related Biosimilars

 
• By Akriti Seth

Cipla has partnered with mAbxience to supply oncology and respiratory-related biosimilars on the WHO model list of essential medicines to South Africa.

South Africa
Partnering companies to get biosimilars in the WHO Model List of Essential Medicines to South Africa • Source: Alamy

More from Deals

More from Business